ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 80 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q1 2022. The put-call ratio across all filers is 4.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $253,592 | +94.8% | 272,681 | +205.8% | 0.00% | – |
| Q4 2022 | $130,190 | -93.9% | 89,171 | -84.3% | 0.00% | -100.0% |
| Q4 2021 | $2,130,000 | -73.5% | 567,796 | -63.5% | 0.00% | -87.9% |
| Q3 2021 | $8,033,000 | +113.2% | 1,553,800 | +312.9% | 0.03% | +26.9% |
| Q2 2020 | $3,768,000 | +10665.7% | 376,340 | +1193.2% | 0.03% | – |
| Q4 2019 | $35,000 | -70.8% | 29,102 | -63.3% | 0.00% | -100.0% |
| Q3 2019 | $120,000 | -84.0% | 79,248 | -39.1% | 0.00% | -87.5% |
| Q4 2018 | $748,000 | -56.0% | 130,050 | -7.8% | 0.01% | -50.0% |
| Q4 2015 | $1,700,000 | – | 140,983 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 6,287,101 | $4,903,939 | 2.63% |
| Syncona Portfolio Ltd | 1,377,294 | $1,074,289 | 1.60% |
| MPM BioImpact LLC | 5,095,912 | $3,974,811 | 1.06% |
| NEA Management Company, LLC | 17,079,778 | $13,322,227 | 1.03% |
| TANG CAPITAL MANAGEMENT LLC | 5,166,954 | $4,030,224 | 0.57% |
| PFM Health Sciences, LP | 10,423,135 | $8,130,045 | 0.38% |
| Matrix Capital Management Company, LP | 38,974,185 | $30,399,864 | 0.36% |
| Long Focus Capital Management, LLC | 10,963,158 | $8,551,263 | 0.31% |
| Acuitas Investments, LLC | 479,764 | $374,216 | 0.22% |
| Endurant Capital Management LP | 311,944 | $243,316 | 0.22% |